Condition: Anorexia Nervosa · Sponsor: COMPASS Pathways
Efficacy and Safety of COMP360 Psilocybin therapy in Anorexia Nervosa: a Proof-of-concept Study
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Altman Clinical and Translational Research Institute | San Diego, California, United States | — |
| Sheppard Pratt Health System | Baltimore, Maryland, United States | — |
| Dell Medical School | Austin, Texas, United States | — |
| Tallaght University Hospital | Dublin, Ireland | — |
| Kings College London, Institute of Psychiatry, Psychology and Neurology | London, United Kingdom | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05481736